Home » Multiplexed Diagnostics Market

Multiplexed Diagnostics Market By Product (Reagents & Consumables, Analyzers), By Application (Disease Diagnostics, Molecular Diagnostics, Drug Development), By Technology (Very High Density Multiplexed Assays, High Density Multiplexed Assays, Medium Density Multiplexed Assays, Low Density Multiplexed Assays, Next Generation Sequencing Assays) – Growth, Future Prospects And Competitive Analysis, 2017 – 2025

Price: $4999

Published: | Report ID: 14279 | Report Format : PDF

Market Insights

Multiplexed diagnostics can detect multiple analytes in a sample in a single run. Multiplexed assays are used in the detection of cancers, infectious diseases, and functional biomolecules such as DNA and mRNA. Multiplexed assays aid in disease diagnosis, molecular diagnosis, and drug development. Multiplexed diagnostics is capable of detecting analytes in a limited sample and in a short span of time by analyzing hundreds of data points simultaneously.

Reagents, consumables, and analyzers make up the global market for multiplexed diagnostics. This report includes a comprehensive market analysis of the global multiplexed diagnostics market for the period 2015–2025. Key insights discussed in this report will provide market stakeholders with a complete understanding of the market and aid in market initiatives, including product launches and investment areas.

The global multiplexed diagnostics market is categorized in terms of product type, technology, application, and geographical distribution. Based on product type, the global multiplexed diagnostics market is segmented into reagents and consumables, and analyzers.

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample
CTA Design Element 3

Based on technology, the global multiplexed diagnostics market is segmented into low-density multiplexed assays, medium-density multiplexed assays, high-density multiplexed assays, very high-density multiplexed assays, and next-generation sequencing assays. The application areas of multiplexed diagnostics are disease diagnostics, molecular diagnostics, and drug development. Each aforementioned segment is analyzed for the years 2015–2025, and CAGRs are calculated for the forecast period.

Based on geographical demarcation, the global multiplexed diagnostics market is segmented into five major regions:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • U.K.
    • Russia
    • Rest of Europe
  • Asia-Pacific
    • India
    • China
    • Japan
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East and Africa

A market analysis of geographical categorization is presented for the period 2015–2025 with CAGRs for the forecast period. Also, the analysis is further sub-segmented in terms of product type, technology, application, and countries.

Along with quantitative analysis of the global multiplexed diagnostics market, this study also provides qualitative evaluation factors for the market. The report provides key insights related to market drivers and restraints, new product launches and approvals, and the competitive strategies of the leading players.

Major players are profiled in the report based on financial performance, product portfolios, and development strategies. Players profiled in this report are F. Hoffmann-La Roche Ltd., Abbott Laboratories, BioMérieux SA, Agilent Technologies, Illumina, Inc., Bio-Rad Laboratories, Hologic, Inc., Siemens Healthineers, Luminex Corporation, Thermo Fisher Scientific, Inc.

The global multiplexed diagnostics market is being studied for their application in the following product types for the purposes of this study:

  • Reagents and consumables
  • Analyzers

Multiplexed diagnostics are efficient diagnostic tests for the diagnosis of cancers, infectious diseases, and personalized medicines. The diagnostic process involves a sample, reagents, and an instrument for result screening. Therefore, the global multiplexed diagnostics market is segmented into reagents and consumables, and analyzers. In terms of market size, analyzers dominate the market due to their high cost and installation charges. The global multiplexed diagnostics market is expanding as research investments and healthcare expenditure rise.

Analyzers are expected to expand at a slower pace due to the availability of rental services provided for analyzers. Analyzers are installed in organizations under the rental scheme, with initial installation and consumables charges. Rental services provide support to the institutes with the lowest budgets for research and development. As a result, the market growth of the analyzers segment is slowed.

However, the reagents and consumables segment is expected to surge at a considerable pace due to increased demand for solutions for the diagnosis of infectious diseases and personalized medicines. The surge in the reagents and consumables segment leads to the overall expansion of the global multiplexed diagnostics market.

For the purpose of this study, the global market for multiplexed diagnostics is studied for their application in the following areas:

  • Disease Diagnostics
  • Molecular Diagnostics
  • Drug Development

Multiplexed diagnostics are utilized in the drug development process, personalized medicines, molecular diagnostics, and the diagnosis of infectious diseases. Molecular diagnostics aid in the understanding of molecular mechanisms and further help in the development of personalized medicines. In terms of market size, the disease diagnostics segment leads the market due to increased adoption in the detection, screening, and monitoring of cancers and infectious diseases.

The disease diagnostics segment is expected to grow at a considerable pace due to the increased prevalence of chronic diseases and acute infections. According to the data provided by the CDC, around 236.968 women were affected by breast cancer in the U.S. in 2014. The rise in the number of cancer cases has increased the demand for multiplexed diagnostic kits.

Furthermore, the molecular diagnostics segment is expected to grow at the fastest rate due to increased investments in research at the molecular level. Increased demand for early disease detection and the adoption of personalized medicine drive the global multiplexed diagnostics market.

For the purpose of this study, the global multiplexed diagnostics market is studied for the following technologies:

  • very high-density multiplexed assays
  • High-Density Multiplexed Assays
  • Medium Density Multiplexed Assays
  • Low-Density Multiplexed Assays
  • Next-Generation Sequencing Assays

The multiplexed diagnostics market was segmented based on the density of the assays. Due to increased demand from pharmaceutical companies and institutes with the intention of rapidly introducing breakthrough drugs in the market, the global multiplexed diagnostics market is expanding.

High- and medium-density assays are expected to lead the market due to their higher cost efficiency and affordability. Other factors contributing to the growth of the market include the introduction of novel products into the market. For instance, Mercodia has introduced the AKURIO Islet Hormones Assay, a multiplex that can detect and quantify glucagon, insulin, C-peptide, and pro-insulin in the same sample.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Based on geographical regions, the global multiplexed diagnostics market is categorized into North America, Asia Pacific, Europe, the Middle East and Africa, and Latin America.

The global multiplexed diagnostics market is dominated by North America, with more than 35% of the total market value. Also, the global multiplexed market is progressing due to growth in the prevalence of cancer and infectious diseases and due to increased investment in the fields of personalized medicine and molecular diagnostics. According to the NIH, an estimated 1,685,210 new cases of cancer were diagnosed in 2016, which is further anticipated to augment through the coming years. These factors contribute to the dominance of North America in the market for the year 2016. North America is followed by Europe and the Asia Pacific.

Increased investments in research and development in the field of molecular diagnostics in developed countries act as a driver for the market in Europe. However, due to the increasing prevalence of breast cancer and other diseases in developing countries, Asia-Pacific has a high potential for the adoption of multiplexed diagnostics, but low affordability restrains the market in this region.

Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase III-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted

Chapter 2. Executive Summary
2.1. Global Multiplexed Diagnostics Market Portraiture
2.1.1. Global Multiplexed Diagnostics Market, by Product Type, 2016 (US$ Mn)
2.1.2. Global Multiplexed Diagnostics Market, by Technology, 2016 (US$ Mn)
2.1.3. Global Multiplexed Diagnostics Market, by Application, 2016 (US$ Mn)
2.1.4. Global Multiplexed Diagnostics Market, by Geography, 2016 (US$ Mn)

Chapter 3. Multiplexed Diagnostics Market: Market Dynamics and Outlook
3.1. Market Definition and Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography
3.6. Value Chain Analysis
3.7. Porter’s Five Forces Model
3.8. Competitive Landscape
3.8.1. Competitive Landscape, by Key Players, 2016

Chapter 4. Multiplexed Diagnostics Market, by Product Type, 2015 – 2025 (US$ Mn)
4.1. Overview
4.1.1. Attractive Investment Proposition, by Product Type, 2016
4.2. Reagents & Consumables
4.3. Analyzers

Chapter 5. Multiplexed Diagnostics Market, by Technology, 2015 – 2025 (US$ Mn)
5.1. Overview
5.1.1. Comparative Analysis: Global Multiplexed Diagnosis Market, by Technology, 2016 Vs 2025 (Value %)
5.2. Very High Density Multiplexed Assays
5.3. High Density Multiplexed Assays
5.4. Medium Density Multiplexed Assays
5.5. Low Density Multiplexed Assays
5.6. Next Generation Sequencing Assays

Chapter 6. Multiplexed Diagnostics Market, by Application, 2015 – 2025 (US$ Mn)
6.1. Overview
6.2. Disease Diagnostics
6.3. Molecular Diagnostics
6.4. Drug Development

Chapter 7. Multiplexed Diagnostics Market, by Geography, 2015 – 2025 (US$ Mn)
7.1. Overview
7.2. North America Multiplexed Diagnostics Market Analysis, 2015 – 2025 (US$ Mn)
7.2.1. North America Multiplexed Diagnostics Market, by Product Type, 2015 – 2025 (US$ Mn)
7.2.2. North America Multiplexed Diagnostics Market, by Technology, 2015 – 2025 (US$ Mn)
7.2.3. North America Multiplexed Diagnostics Market, by Application, 2015 – 2025 (US$ Mn)
7.2.4. North America Multiplexed Diagnostics Market, by Country, 2015 – 2025 (US$ Mn)
7.2.4.1. U.S.
7.2.4.2. Canada
7.3. Europe Multiplexed Diagnostics Market Analysis, 2015 – 2025 (US$ Mn)
7.3.1. Europe Multiplexed Diagnostics Market, by Product Type, 2015 – 2025 (US$ Mn)
7.3.2. Europe Multiplexed Diagnostics Market, by Technology, 2015 – 2025 (US$ Mn)
7.3.3. Europe Multiplexed Diagnostics Market, by Application, 2015 – 2025 (US$ Mn)
7.3.4. Europe Multiplexed Diagnostics Market, by Country, 2015 – 2025 (US$ Mn)
7.3.4.1. U.K.
7.3.4.2. Germany
7.3.4.3. Rest of Europe
7.4. Asia Pacific Multiplexed Diagnostics Market Analysis, 2015 – 2025 (US$ Mn)
7.4.1. Asia Pacific Multiplexed Diagnostics Market, by Product Type, 2015 – 2025 (US$ Mn)
7.4.2. Asia Pacific Multiplexed Diagnostics Market, by Technology, 2015 – 2025 (US$ Mn)
7.4.3. Asia Pacific Multiplexed Diagnostics Market, by Application, 2015 – 2025 (US$ Mn)
7.4.4. Asia Pacific Multiplexed Diagnostics Market, by Country, 2015 – 2025 (US$ Mn)
7.4.4.1. China
7.4.4.2. Japan
7.4.4.3. Rest of APAC
7.5. Latin America Multiplexed Diagnostics Market Analysis , 2015 – 2025 (US$ Mn)
7.5.1. Latin America Multiplexed Diagnostics Market, by Product Type, 2015 – 2025 (US$ Mn)
7.5.2. Latin America Multiplexed Diagnostics Market, by Technology, 2015 – 2025 (US$ Mn)
7.5.3. Latin America Multiplexed Diagnostics Market, by Application, 2015 – 2025 (US$ Mn)
7.5.4. Latin America Multiplexed Diagnostics Market, by Country, 2015 – 2025 (US$ Mn)
7.5.4.1. Brazil
7.5.4.2. Mexico
7.5.4.3. Rest of Latin America
7.6. Middle East & Africa (MEA) Multiplexed Diagnostics Market Analysis, 2015 – 2025 (US$ Mn)
7.6.1. MEA Multiplexed Diagnostics Market, by Product Type, 2015 – 2025 (US$ Mn)
7.6.2. MEA Multiplexed Diagnostics Market, by Technology, 2015 – 2025 (US$ Mn)
7.6.3. MEA Multiplexed Diagnostics Market, by Application, 2015 – 2025 (US$ Mn)
7.6.4. MEA Multiplexed Diagnostics Market, by Region, 2015 – 2025 (US$ Mn)
7.6.4.1. GCC
7.6.4.2. Rest of MEA

Chapter 8. Company Profiles
8.1. Abbott Laboratories
8.1.1. Business Description
8.1.2. Financial Information (Subject to data availability)
8.1.3. Application Portfolio
8.1.4. Key Developments
8.2. Agilent Technologies
8.3. Baxter International, Inc.
8.4. BioMérieux SA
8.5. Bio-Rad Laboratories
8.6. F. Hoffmann-La Roche Ltd.
8.7. Hologic, Inc.
8.8. Illumina, Inc.
8.9. Luminex Corporation
8.10. Siemens Healthineers
8.11. Thermo Fisher Scientific, Inc.

List of Figures

FIG. 1 Multiplexed Diagnostics: Market Segmentation
FIG. 2 Global Multiplexed Diagnostics Market, by Product Type, 2016 (US$ Mn)
FIG. 3 Global Multiplexed Diagnostics Market, by Technology, 2016 (US$ Mn)
FIG. 4 Global Multiplexed Diagnostics Market, by Application, 2016 (US$ Mn)
FIG. 5 Global Multiplexed Diagnostics Market, by Geography, 2016 (Value %)
FIG. 6 Attractive Investment Proposition, by Geography
FIG. 7 Market Competition Landscape, by Key Players, 2016
FIG. 8 Global Reagents & Consumables Market, 2015 – 2025 (US$ Mn)
FIG. 9 Global Analyzers Market, 2015 – 2025 (US$ Mn)
FIG. 10 Global Very High Density Multiplexed Assays Market, 2015 – 2025 (US$ Mn)
FIG. 11 Global High Density Multiplexed Assays Market, 2015 – 2025 (US$ Mn)
FIG. 12 Global Medium Density Multiplexed Assays Market, 2015 – 2025 (US$ Mn)
FIG. 13 Global Low Density Multiplexed Assays Market, 2015 – 2025 (US$ Mn)
FIG. 14 Global Next Generation Sequencing Assays Market, 2015 – 2025 (US$ Mn)
FIG. 15 Global Disease Diagnostics Multiplexed Diagnostics Market, 2015 – 2025 (US$ Mn)
FIG. 16 Global Molecular Diagnostics Multiplexed Diagnostics Market, 2015 – 2025 (US$ Mn)
FIG. 17 Global Drug Development Multiplexed Diagnostics Market, 2015 – 2025 (US$ Mn)
FIG. 18 U.S. Multiplexed Diagnostics Market, 2015 – 2025 (US$ Mn)
FIG. 19 Canada Multiplexed Diagnostics Market, 2015 – 2025 (US$ Mn)
FIG. 20 U.K. Multiplexed Diagnostics Market, 2015 – 2025 (US$ Mn)
FIG. 21 Germany Multiplexed Diagnostics Market, 2015 – 2025 (US$ Mn)
FIG. 22 Rest of Europe Multiplexed Diagnostics Market, 2015 – 2025 (US$ Mn)
FIG. 23 Japan Multiplexed Diagnostics Market, 2015 – 2025 (US$ Mn)
FIG. 24 China Multiplexed Diagnostics Market, 2015 – 2025 (US$ Mn)
FIG. 25 Rest of Asia Pacific Multiplexed Diagnostics Market, 2015 – 2025 (US$ Mn)
FIG. 26 Brazil Multiplexed Diagnostics Market, 2015 – 2025 (US$ Mn)
FIG. 27 Mexico Multiplexed Diagnostics Market, 2015 – 2025 (US$ Mn)
FIG. 28 Rest of Latin America Multiplexed Diagnostics Market, 2015 – 2025 (US$ Mn)
FIG. 29 GCC Multiplexed Diagnostics Market, 2015 – 2025 (US$ Mn)
FIG. 30 Rest of Middle East and Africa Multiplexed Diagnostics Market, 2015 – 2025 (US$ Mn)

List of Tables

TABLE 1 Global Multiplexed Diagnostics Market Portraiture
TABLE 2 Global Multiplexed Diagnostics Market, by Product Type, 2015 – 2025 (US$ Mn)
TABLE 3 Global Multiplexed Diagnostics Market, by Technology, 2015 – 2025 (US$ Mn)
TABLE 4 Global Multiplexed Diagnostics Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 5 Global Multiplexed Diagnostics Market, by Geography, 2015 – 2025 (US$ Mn)
TABLE 6 North America Multiplexed Diagnostics Market, by Product Type, 2015 – 2025 (US$ Mn)
TABLE 7 North America Multiplexed Diagnostics Market, by Technology, 2015 – 2025 (US$ Mn)
TABLE 8 North America Multiplexed Diagnostics Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 9 North America Multiplexed Diagnostics Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 10 Europe Multiplexed Diagnostics Market, by Product Type, 2015 – 2025 (US$ Mn)
TABLE 11 Europe Multiplexed Diagnostics Market, by Technology, 2015 – 2025 (US$ Mn)
TABLE 12 Europe Multiplexed Diagnostics Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 13 Europe Multiplexed Diagnostics Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 14 Asia Pacific Multiplexed Diagnostics Market, by Product Type, 2015 – 2025 (US$ Mn)
TABLE 15 Asia Pacific Multiplexed Diagnostics Market, by Technology, 2015 – 2025 (US$ Mn)
TABLE 16 Asia Pacific Multiplexed Diagnostics Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 17 Asia Pacific Multiplexed Diagnostics Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 18 Latin America Multiplexed Diagnostics Market, by Product Type, 2015 – 2025 (US$ Mn)
TABLE 19 Latin America Multiplexed Diagnostics Market, by Technology, 2015 – 2025 (US$ Mn)
TABLE 20 Latin America Multiplexed Diagnostics Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 21 Latin America Multiplexed Diagnostics Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 22 Middle East and Africa Multiplexed Diagnostics Market, by Product Type, 2015 – 2025 (US$ Mn)
TABLE 23 Middle East and Africa Multiplexed Diagnostics Market, by Technology, 2015 – 2025 (US$ Mn)
TABLE 24 Middle East and Africa Multiplexed Diagnostics Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 25 Middle East and Africa Multiplexed Diagnostics Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 26 Abbott Laboratories: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 27 Agilent Technologies: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 28 BioMérieux SA: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 29 Bio-Rad Laboratories: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 30 F. Hoffmann-La Roche Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 31 Hologic, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 32 Illumina, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 33 Luminex Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 34 Siemens Healthineers: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 35 Thermo Fisher Scientific, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)

Frequently Asked Question:

What is the size of Multiplexed Diagnostics Market?

The market for Multiplexed Diagnostics Market is expected to reach USD$ 17.85 Bn in 2025.

What is the Multiplexed Diagnostics Market CAGR?

The Multiplexed Diagnostics Market is expected to see significant CAGR growth over the coming years, at 9.4%.

What is the Forecast period considered for Multiplexed Diagnostics Market?

The report is forecasted from 2017 -2025.

What is the base year considered for Multiplexed Diagnostics Market?

The base year of this report is 2016.

Who are the major players in this market?

F. Hoffmann-La Roche Ltd., Abbott Laboratories, BioMérieux SA, Agilent Technologies, Illumina, Inc. are some of the major players in the global market.

MRI Guided Neurosurgical Ablation Market

Published:
Report ID: 33742

Glycated Albumin Assay Market

Published:
Report ID: 33574

Proliferative Diabetic Retinopathy Market

Published:
Report ID: 33536

Endoscopic Ultrasound (EUS) Needles Market

Published:
Report ID: 4131

Healthcare POS Terminals Market

Published:
Report ID: 13903

Optogenetics Market

Published:
Report ID: 8143

Medical Robotics Market

Published:
Report ID: 14075

Ablation Devices Market

Published:
Report ID: 1062

Medical Imaging Reagents Market

Published:
Report ID: 8770

X-Ray Security Screening Market

Published:
Report ID: 9312

Metal Implants and Medical Alloys Market

Published:
Report ID: 32899

Purchase Options

$2999
Delivery Format: Excel.
$4999
Designed for the individual purchaser.
$6999
Users located at a single corporate site or regional office.
$7999
Allowed for unlimited sharing globally within one company.
Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN